company insight

HOF Sonderanlagenbau
Quality is key...

Hot Freeze Drying Systems -
The specialist for individual solutions.

01 / What makes HOF unique?

Founded in 1988, HOF has developed to one of the top suppliers for pharmaceutical freeze-drying equipment, meaning freeze dryers from the laboratory scale up to production maximal production sizes, as well as specific loading and unloading devices. Furthermore, units for rapid freezing and thawing of medical and biotech products are part of our portfolio.

Nevertheless, HOF has no standard product catalogue: every system or installation is individually designed for the customer’s needs – performance parameters, space availability and room limitations as well as specified components and materials are incorporated.

“Just in time quality for our demanding customers is our valid philosophy for every single project”

02 / The name HOF stands for…

…advise, innovation, technology, manufacture, quality and expertise. These six arguments are the fundamental basis for every project. All departments and groups involved in a customized project adjust their actions towards these criteria, always focusing on the company’s philosophy and therefore to meet all expectations towards quality, functionality and timing.


Beginning with the first Draft-Layout and the review of the ‘user requirement specification’, all parties involved work hand in hand to maximize the efficiency in the workflow and to present the best results possible. This claim is met throughout the complete runtime of a project until the final acceptance tests at the customer’s site.

all parties involved work hand in hand to maximize the efficiency in the workflow and to present the best results possible

03 / What are the strengths of HOF?

…advise, innovation, technology, manufacture, quality and expertise. These six arguments are the fundamental basis for every project. All departments and groups involved in a customized project adjust their actions towards these criteria, always focusing on the company’s philosophy and therefore to meet all expectations towards quality, functionality and timing.


Beginning with the first Draft-Layout and the review of the ‘user requirement specification’, all parties involved work hand in hand to maximize the efficiency in the workflow and to present the best results possible. This claim is met throughout the complete runtime of a project until the final acceptance tests at the customer’s site.

04 / What do you do in order to be innovative?

For more than 25 years, HOF Sonderanlagenbau GmbH has been developing for-ward-looking technologies, nationally and internationally. An important requirement for all company departments is to develop and plan the future today. HOF employees focus on the technological innovations with the objective to meet new customers’ specific requirements.

The company’s aim for the future is to remain an innovative pioneer in research and development of freeze-drying systems. innovative charging systems, flexible shelf adjustment, use of liquid nitrogen and natural refrigerants, control integration of advanced measuring systems such as NIR and mass spectrometers, HOF SynchroFreeze and vacuum insulation: these are some examples for the company‘s innovative potential and willingness to take on new approaches.

HOF SynchroFreeze is a future oriented technology. This procedure allows a homogeneous freezing thanks to a synchronized nucleation during the freezing process – with a simultaneous reduction of the drying time.

05 / What is the benefit of the innovation HOF SynchroFreeze?

HOF SynchroFreeze is a future oriented technology. This procedure allows a homogeneous freezing thanks to a synchronized nucleation during the freezing process – with a simultaneous reduction of the drying time.

This innovation of HOF, registered for patent approval, provides the customer with further tools to quality improvement of the pharmaceutical product and to more efficiency. 


HOF SynchroFreeze distinguishes itself through a high process reliability and the possibility for retrofitting of existing freeze-drying systems.

Brief Overview of HOF SynchroFreeze:
•  Synchronization of freezing process in individual vials and product containers
•  Increase of the product homogeneity
•  Conditioning of product structure
•  Reduction of drying times

Share this article

Go to article: Home | Trust In Big PharmaGo to article: EditorialGo to article: NSFGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: FreudenbergGo to article: The Pharma Industry BriefingGo to article: Fisher Clinical Services Company InsightGo to article: Fisher Clinical ServicesGo to article: The People vs Big Pharma: tackling the industry’s trust issuesGo to article: Scandinavian Health Ltd. Company InsightGo to article: Scandinavian Health Ltd.Go to article: Humira: the highs and lows of the world’s most successful drug Go to article: Wilhelm Haselmeier GmbH & Co KG Company InsightGo to article: Wilhelm Haselmeier GmbH & Co. KGGo to article: Gene therapy: talking smart solutions with Bluebird BioGo to article: Moehs Iberica Company InsightGo to article: Moehs Iberica SLGo to article: A research headache: improving the understanding of chronic migraine Go to article: SensitechGo to article: HOF Sonderanlagenbau Company InsightGo to article: HOF SonderanlagenbauGo to article: Philanthropy in pharma: a look inside the ISPE FoundationGo to article: DelSiTechGo to article: Novel Oral Therapies Are An Unmet Need For Ulcerative ColitisGo to article: PhoenixGo to article: FDA removes key barrier to US biosimilar developmentGo to article: Nipro PharmaPackagingGo to article: Pfizer price hikes: do rare cancer drugs warrant higher prices?Go to article: AlpexGo to article: Head-to-head: competing for the most effective psoriasis drugGo to article: Mecmesin Company InsightGo to article: MecmesinGo to article: Takeda to seek label expansion for Ninlaro in multiple myelomaGo to article: Capsugel Company InsightGo to article: Contract Pharmaceuticals Limited CanadaGo to article: Epilepsy: Zogenix’s ZX008 set for showdown with GW Pharma’s EpidiolexGo to article: EcocoolGo to article: Abiogen PharmaGo to article: Illegal online pharmacies: how endemic are they?Go to article: Global Freight Solutions LtdGo to article: The boom in medical cannabis research is set to continueGo to article: AtoZ-CRO GmbH Company InsightGo to article: AtoZ-CRO GmbHGo to article: Population boom will boost acute stroke market, particularly in ChinaGo to article: Pall BiotechGo to article: Cryo StoreGo to article: Watch Alibaba instead of Amazon in healthcareGo to article: WIKA - Disaster preventionGo to article: AstraZeneca’s Lynparza maintains lead in PARP inhibitor raceGo to article: G.F.Go to article: Erdmann Design SwitzerlandGo to article: CMV presents a serious concern in HIV+ personsGo to article: BEA TechnologiesGo to article: BaxterGo to article: bDMARD therapy: adherence in the first year is key to successGo to article: Pharma Support Services Ltd Company InsightGo to article: Pharma Support Services LtdGo to article: End the struggle: pathways to HEAL the opioid crisisGo to article: LaudaGo to article: AbbVie poised to overtake Gilead as hepatitis C leaderGo to article: ILC Dover IncGo to article: ViiV results show the importance of INIs to future HIV treatmentGo to article: PfanstiehlGo to article: Novartis acquires rights to atopic dermatitis candidate MOR106Go to article: Niconex Medical LtdGo to article: EventsGo to article: Next issue